News
T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...
Download Cerba Research's new report to discover how to overcome immunogenicity and safety challenges in oncology.
The Global Outbreak Alert and Response Network (GOARN), an initiative coordinated by the World Health Organization (WHO), ...
The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...
Find out how to select the ideal pump for dialysis machines, ensuring precise fluid control, reliability, and patient safety.
Follow Bruker's experts as they discuss the SCRUM approach to software development in the scientific industry.
Andrés Aguilera's laboratory, in collaboration with that of Ralf Wellinger (both professors in the Department of Genetics at the University of Seville in CABIMER) and with PharmaMAR, has identified ...
A world-first clinical trial launched in Melbourne is being hailed a ‘game-changer’ for its potential to revolutionize the ...
When a person sustains an injury to the spinal cord, the normal communication between the brain and the spinal circuits below the injury are interrupted, resulting in paralysis.
Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma
Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell ...
In a comprehensive Genomic Press Interview, researchers from UTHealth Houston have uncovered crucial evidence that substance use disorders (SUDs) accelerate biological aging in the brain through ...
Depression in young teens could be easier to treat than in adulthood due to the symptoms being more flexible and not yet ingrained, a study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results